The 7th Canadian Symposium on Hepatitis C Virus: "Toward Elimination of HCV: How to Get There" [0.03%]
第七届加拿大丙型肝炎病毒研讨会：“迈向丙型肝炎的消除：如何实现目标”
Michael L Cheng,Mohamed S Abdel-Hakeem,Sophie E Cousineau et al.
Michael L Cheng et al.
Hepatitis C virus (HCV) affects more than 268,000 people in Canada. Both the Canadian Institutes of Health Research and the Public Health Agency of Canada recognize the significant impact of HCV-related liver diseases and supported the esta...
John Lm Law,Mike Logan,Amir Landi et al.
John Lm Law et al.
New effective drugs to treat hepatitis C (HCV) promise to cure nearly all patients, but relying solely on antivirals without an effective vaccine has been ineffective in eliminating all other infectious diseases. A prophylactic HCV vaccine ...
In the eyes of Indigenous people in Canada: exposing the underlying colonial etiology of hepatitis C and the imperative for trauma-informed care [0.03%]
加拿大原住民眼中的丙型肝炎：揭露殖民渊源及开展创伤知情照护的必要性
Sadeem T Fayed,Alexandra King,Malcolm King et al.
Sadeem T Fayed et al.
Background: The distribution of hepatitis C (HCV) infection in Canada signals a widening gap between Indigenous and non-Indigenous people. Current evidence demonstrates that the rate of HCV infection among Indigenous peop...
Descriptive epidemiology of hepatitis C in individuals referred for specialized HCV care in Newfoundland and Labrador, 1996-2014 [0.03%]
1996-2014年推荐接受专业丙型肝炎治疗的加拿大纽芬兰与拉布拉多省居民的丙型肝炎描述性流行病学研究
Mary Malebranche,Dawn King,Jennifer Leonard
Mary Malebranche
Background: Despite growing awareness of the significant burden of disease caused by hepatitis C virus (HCV) infection worldwide, understanding of the epidemiology and demographic distribution of HCV infection in Canada, ...
Barriers to hepatitis C diagnosis and treatment in the DAA era: Preliminary results of a community-based survey of primary care practitioners [0.03%]
直接抗病毒药物时代HCV诊断和治疗障碍的社区初级保健医生调查初步结果分析
Sanjeev Sirpal,Natasha Chandok
Sanjeev Sirpal
Notwithstanding the groundbreaking achievement of hepatitis C curative treatment with direct-acting antiviral therapies, Canada faces an uphill battle in reaching the 2030 goal of viral elimination set forth by the World Health Organization...
Non-alcoholic fatty liver disease (NAFLD) in Filipino North American patients: Results from a multi-ethnic cohort [0.03%]
非酒精性脂肪肝病(NAFLD)在菲律宾裔美国患者中的患病率：来自多族裔队列的结果
Shirley X Jiang,Roberto Trasolini,Michael Heer et al.
Shirley X Jiang et al.
Background: Non-alcoholic fatty liver disease (NAFLD) is more prevalent in certain ethnicities due to a combination of genetic, environmental, and metabolic factors. North American Filipino populations may have lifestyle ...
Gerald Y Minuk
Gerald Y Minuk
Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH) [0.03%]
非酒精性脂肪肝病临床管理及护理的当前考虑因素：来自加拿大非酒精性 steatohepatitis 网络（CanNASH）首届国际研讨会的见解
Giada Sebastiani,Keyur Patel,Vlad Ratziu et al.
Giada Sebastiani et al.
Non-alcoholic fatty liver disease (NAFLD) affects approximately 8 million Canadians. NAFLD refers to a disease spectrum ranging from bland steatosis to non-alcoholic steatohepatitis (NASH). Nearly 25% of patients with NAFLD develop NASH, wh...
Serum IgG4 cut-off of 70 mg/dL is associated with a shorter time to cirrhosis decompensation and liver transplantation in primary sclerosing cholangitis patients [0.03%]
原发性硬化性胆管炎患者中，IgG4的血清切割值为70毫克/天与肝失代偿和肝脏移植术的时间缩短有关
Farhad Peerani,Lillian Du,Ellina Lytvyak et al.
Farhad Peerani et al.
Background: Primary sclerosing cholangitis (PSC) is an immune-mediated biliary disorder of unknown etiology with no effective treatment. The purpose of this study was to better prognosticate the development of cirrhosis, ...
Hepatotoxicity during legacy cancer chemotherapy in patients infected with hepatitis C virus: A retrospective cohort study [0.03%]
丙型肝炎病毒感染患者接受传统癌症化疗期间的肝毒性：一项基于队列的研究
Jean-Luc Szpakowski,Lue-Yen Tucker,David M Baer et al.
Jean-Luc Szpakowski et al.
Background: The rates and causes of significant hepatotoxicity with cancer chemotherapy (CCT) in patients infected with hepatitis C virus (HCV) are incompletely characterized. ...